Romanovskis P, Spatola A F
Department of Chemistry, University of Louisville, Kentucky 40292, USA.
J Pept Res. 1998 Nov;52(5):356-74. doi: 10.1111/j.1399-3011.1998.tb00660.x.
Cyclic peptide mixtures represent a promising approach for drug lead discovery. Diversity can be expanded via changes in ring size, amide bond replacements, D- and L-natural and unnatural amino acids, and by the incorporation of beta-turn mimics and related conformational constraints. We expand the scope of our side-chain attachment/resin-bound cyclization strategy first developed using aspartic acid, asparagine, and elated acid-based attachments. In this report, we describe the preparation and use of Boc-Lys-OFm, Boc-Orn-OFm, and Boc-Dab-OFm. The synthetic strategies were verified by the independent synthesis of two small RGD-based cyclic mixtures, cyclo(Pro-Xxx-Lys-Arg-Gly-Asp), where Xxx = Ala, Ser, Leu, Tyr, using Boc-Asp-OFm, and then Boc-Lys-OFm for the initial resin-bound side-chain linkage. A new orthogonal synthetic approach to cyclic peptides, based on the use of the paranitrobenzyl (ONB) ester for alpha-carboxyl protection (selectively cleaved via SnCl2 reduction), was developed. It led to the successful synthesis of individual cyclic pentapeptides using serine (Boc-Ser-ONB), and tyrosine (Fmoc-Tyr-ONB) as the side chain-linked residues.
环肽混合物是药物先导发现的一种有前景的方法。可以通过改变环大小、酰胺键替换、D-和L-天然及非天然氨基酸,以及引入β-转角模拟物和相关构象限制来扩大多样性。我们扩展了最初使用天冬氨酸、天冬酰胺和基于兴奋酸的连接基团开发的侧链连接/树脂结合环化策略的范围。在本报告中,我们描述了Boc-Lys-OFm、Boc-Orn-OFm和Boc-Dab-OFm的制备和使用。通过独立合成两种基于RGD的小环肽混合物,即环(Pro-Xxx-Lys-Arg-Gly-Asp),其中Xxx = Ala、Ser、Leu、Tyr,使用Boc-Asp-OFm,然后使用Boc-Lys-OFm进行初始树脂结合侧链连接,验证了合成策略。开发了一种基于使用对硝基苄基(ONB)酯进行α-羧基保护(通过SnCl2还原选择性裂解)的环肽正交合成新方法。它导致使用丝氨酸(Boc-Ser-ONB)和酪氨酸(Fmoc-Tyr-ONB)作为侧链连接残基成功合成了单个环五肽。